Skip to main content
. Author manuscript; available in PMC: 2023 Dec 3.
Published in final edited form as: Blood Rev. 2022 Aug 2;57:100996. doi: 10.1016/j.blre.2022.100996

Fig. 2.

Fig. 2.

Pro-survival proteins and apoptosis in acute myeloid leukemia.

MCL-1 and BCL-2 are pro-survival proteins that are frequently targeted or dysregulated in AML. Venetoclax is a BCL-2 inhibitor that results in apoptosis through mitochondrial cytochrome C release. BCL-2 resistance can occur through up-regulation of MCL-1, which can be overcome through suppression of the RAS pathway by p53.